Package | eu.epi.february2025 |
Type | CodeSystem |
Id | Id |
FHIR Version | R5 |
Source | https://simplifier.net/resolve?scope=eu.epi.february2025@1.0.0&canonical=http://ema.europa.eu/fhir/CodeSystem/300000000002 |
Url | http://ema.europa.eu/fhir/CodeSystem/300000000002 |
Version | 5.0.0 |
Status | active |
Name | EUepiannexIIcodesystem |
Title | EU EPI Annex II QRD code values |
Experimental | False |
Description | EU EPI Annex II QRD code values |
Content | complete |
No resources found
No resources found
{
"resourceType" : "CodeSystem",
"status" : "active",
"content" : "complete",
"name" : "EUepiannexIIcodesystem",
"id" : "300000000002",
"title" : "EU EPI Annex II QRD code values",
"description" : "EU EPI Annex II QRD code values",
"version" : "5.0.0",
"url" : "http://ema.europa.eu/fhir/CodeSystem/300000000002",
"concept" : [
{
"code" : "000000000000",
"display" : "Code for custom sub-sections (reserved)"
},
{
"code" : "200000029850",
"display" : "ANNEX II"
},
{
"code" : "200000029851",
"display" : "A. <MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND> MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE"
},
{
"code" : "200000029852",
"display" : "B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE"
},
{
"code" : "200000029853",
"display" : "Official batch release"
},
{
"code" : "200000029854",
"display" : "C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION"
},
{
"code" : "200000029855",
"display" : "Periodic safety update reports (PSURs)"
},
{
"code" : "200000029856",
"display" : "D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT"
},
{
"code" : "200000029857",
"display" : "Risk management plan (RMP)"
},
{
"code" : "200000029858",
"display" : "Additional risk minimisation measures"
},
{
"code" : "200000029859",
"display" : "Obligation to conduct post-authorisation measures"
},
{
"code" : "200000029860",
"display" : "E. SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR <THE CONDITIONAL MARKETING AUTHORISATION> <THE MARKETING AUTHORISATION UNDER EXCEPTIONAL CIRCUMSTANCES"
}
],
"experimental" : false,
"publisher" : "European Medicines Agency",
"jurisdiction" : [
{
"text" : "European Union"
}
],
"caseSensitive" : true,
"count" : 12,
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.